These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25800114)

  • 1. Three-dimensional rational approach to the discovery of potent substituted cyclopropyl urea soluble epoxide hydrolase inhibitors.
    Takai K; Chiyo N; Nakajima T; Nariai T; Ishikawa C; Nakatani S; Ikeno A; Yamamoto S; Sone T
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1705-1708. PubMed ID: 25800114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based optimization of cyclopropyl urea derivatives as potent soluble epoxide hydrolase inhibitors for potential decrease of renal injury without hypotensive action.
    Takai K; Nakajima T; Takanashi Y; Sone T; Nariai T; Chiyo N; Nakatani S; Ishikawa C; Yamaguchi N; Fujita K; Yamada K
    Bioorg Med Chem; 2014 Mar; 22(5):1548-57. PubMed ID: 24530032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis.
    Du F; Sun W; Morisseau C; Hammock BD; Bao X; Liu Q; Wang C; Zhang T; Yang H; Zhou J; Xiao W; Liu Z; Chen G
    Eur J Med Chem; 2021 Nov; 223():113678. PubMed ID: 34218083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA.
    Karami L; Saboury AA; Rezaee E; Tabatabai SA
    Eur Biophys J; 2017 Jul; 46(5):445-459. PubMed ID: 27928588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 2,8-diazaspiro[4.5]decane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating hypertension.
    Kato Y; Fuchi N; Saburi H; Nishimura Y; Watanabe A; Yagi M; Nakadera Y; Higashi E; Yamada M; Aoki T
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5975-9. PubMed ID: 24035338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into binding of inhibitors to soluble epoxide hydrolase gained by fragment screening and X-ray crystallography.
    Amano Y; Yamaguchi T; Tanabe E
    Bioorg Med Chem; 2014 Apr; 22(8):2427-34. PubMed ID: 24656800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Potent Soluble Epoxide Hydrolase (sEH) Inhibitors by Pharmacophore-Based Virtual Screening.
    Waltenberger B; Garscha U; Temml V; Liers J; Werz O; Schuster D; Stuppner H
    J Chem Inf Model; 2016 Apr; 56(4):747-62. PubMed ID: 26882208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors.
    Shen HC; Ding FX; Deng Q; Xu S; Chen HS; Tong X; Tong V; Zhang X; Chen Y; Zhou G; Pai LY; Alonso-Galicia M; Zhang B; Roy S; Tata JR; Berger JP; Colletti SL
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5314-20. PubMed ID: 19682899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitors.
    Shen HC; Ding FX; Deng Q; Xu S; Tong X; Zhang X; Chen Y; Zhou G; Pai LY; Alonso-Galicia M; Roy S; Zhang B; Tata JR; Berger JP; Colletti SL
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5716-21. PubMed ID: 19700315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into the binding modes and inhibition mechanisms of adamantyl-based 1,3-disubstituted urea inhibitors in the active site of the human soluble epoxide hydrolase.
    Chen H; Zhang Y; Ye C; Feng TT; Han JG
    J Biomol Struct Dyn; 2014; 32(8):1231-47. PubMed ID: 23815795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase.
    Jones PD; Tsai HJ; Do ZN; Morisseau C; Hammock BD
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5212-6. PubMed ID: 16870439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of 1-oxa-4,9-diazaspiro[5.5]undecane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating of chronic kidney diseases.
    Kato Y; Fuchi N; Nishimura Y; Watanabe A; Yagi M; Nakadera Y; Higashi E; Yamada M; Aoki T; Kigoshi H
    Bioorg Med Chem Lett; 2014 Jan; 24(2):565-70. PubMed ID: 24373724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imidazolidine-2,4,5- and pirimidine-2,4,6-triones - New primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility.
    Burmistrov V; Morisseau C; D'yachenko V; Karlov D; Butov GM; Hammock BD
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126908. PubMed ID: 31870649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptidyl-urea based inhibitors of soluble epoxide hydrolases.
    Morisseau C; Newman JW; Tsai HJ; Baecker PA; Hammock BD
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5439-44. PubMed ID: 16908134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent urea and carbamate inhibitors of soluble epoxide hydrolases.
    Morisseau C; Goodrow MH; Dowdy D; Zheng J; Greene JF; Sanborn JR; Hammock BD
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):8849-54. PubMed ID: 10430859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Therapeutic Potential of Sulfonyl Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors.
    Kundu B; Dvorácskó S; Basu A; Pommerolle L; Kim KA; Wood CM; Gibbs E; Behee M; Tarasova NI; Cinar R; Iyer MR
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38998987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N'-diaryl urea inhibitors of soluble epoxide hydrolase.
    Anandan SK; Gless RD
    Bioorg Med Chem Lett; 2010 May; 20(9):2740-4. PubMed ID: 20363133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and Optimization of Piperazine Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors.
    Çapan İ; Jordan PM; Olğaç A; Çalışkan B; Kretzer C; Werz O; Banoglu E
    ChemMedChem; 2022 Jun; 17(12):e202200137. PubMed ID: 35466565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitors.
    Shen HC; Ding FX; Wang S; Xu S; Chen HS; Tong X; Tong V; Mitra K; Kumar S; Zhang X; Chen Y; Zhou G; Pai LY; Alonso-Galicia M; Chen X; Zhang B; Tata JR; Berger JP; Colletti SL
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3398-404. PubMed ID: 19481932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of enantioselectivity of urea inhibitors of soluble epoxide hydrolase.
    Manickam M; Pillaiyar T; Boggu P; Venkateswararao E; Jalani HB; Kim ND; Lee SK; Jeon JS; Kim SK; Jung SH
    Eur J Med Chem; 2016 Jul; 117():113-24. PubMed ID: 27092411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.